{"filing":{"accession_number":"0001628280-26-066291","cik":"0001613103","ticker":"MDT","company_name":"Medtronic plc","form":"8-K","filing_date":"2026-10-19","report_date":"2026-10-15","primary_document":"mdt-20261015.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026066291/mdt-20261015.htm"},"events":[{"id":36102,"run_id":33287,"accession_number":"0001628280-26-066291","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Michael Marinaro was appointed to the expanded role of President, Medtronic, effective October 14, 2026, with expanded responsibilities including oversight of Greater China operations. The appointment includes a salary increase to $1,000,000 and supplemental long-term incentive awards totaling $3.25 million.","company_name":"Medtronic plc","ticker":"MDT","filing_date":"2026-10-19","form":"8-K","submitted_at":null,"items":[{"id":40391,"accession_number":"0001628280-26-066291","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Michael Marinaro was appointed to the expanded role of President, Medtronic, effective October 14, 2026, by the Board of Directors on October 15, 2026. While the disclosure also includes compensatory arrangements (salary increase to $1,000,000 and supplemental long-term incentive awards totaling $3.25 million), the principal disclosed action is the appointment to a significant executive position with expanded responsibilities including oversight of Greater China operations. This is material to investors as it reflects a key leadership change in the company's organizational structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:25:42.724460+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":36103,"run_id":33287,"accession_number":"0001628280-26-066291","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Medtronic's October 15, 2026 Annual General Meeting resulted in shareholder approval of six proposals: election of twelve directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory vote on named executive officer compensation, renewal of board authority to issue shares, renewal of pre-emption rights opt-out authority, and authorization for share repurchases.","company_name":"Medtronic plc","ticker":"MDT","filing_date":"2026-10-19","form":"8-K","submitted_at":null,"items":[{"id":40392,"accession_number":"0001628280-26-066291","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Item 5.07 discloses the results of Medtronic's October 15, 2026 Annual General Meeting, including voting outcomes on six proposals: election of twelve directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory vote on named executive officer compensation, renewal of board authority to issue shares, renewal of pre-emption rights opt-out authority, and authorization for share repurchases. The filing presents detailed voting tallies (FOR, AGAINST, ABSTAIN, BROKER NON-VOTE) for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:25:42.724460+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":36104,"run_id":33287,"accession_number":"0001628280-26-066291","anchor_item_number":"7.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"Medtronic completed the separation of MiniMed Group, Inc., exchanging all remaining 252,813,348 shares of MiniMed common stock for Medtronic ordinary shares, representing the completion of a material disposition and change of control event affecting the registrant's asset base and strategic focus.","company_name":"Medtronic plc","ticker":"MDT","filing_date":"2026-10-19","form":"8-K","submitted_at":null,"items":[{"id":40393,"accession_number":"0001628280-26-066291","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Medtronic announced the completion of its separation of MiniMed Group, Inc., including settlement of an exchange offer whereby Medtronic exchanged all remaining shares of MiniMed common stock (252,813,348 shares) for Medtronic ordinary shares. This represents the completion of a material disposition and change of control event—a spin-off or separation of a significant business unit that would materially affect the registrant's asset base and strategic focus.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:25:42.724460+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40391,"accession_number":"0001628280-26-066291","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Michael Marinaro was appointed to the expanded role of President, Medtronic, effective October 14, 2026, by the Board of Directors on October 15, 2026. While the disclosure also includes compensatory arrangements (salary increase to $1,000,000 and supplemental long-term incentive awards totaling $3.25 million), the principal disclosed action is the appointment to a significant executive position with expanded responsibilities including oversight of Greater China operations. This is material to investors as it reflects a key leadership change in the company's organizational structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:25:42.724460+00:00","company_name":"Medtronic plc","ticker":"MDT","filing_date":"2026-10-19"},{"id":40392,"accession_number":"0001628280-26-066291","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Item 5.07 discloses the results of Medtronic's October 15, 2026 Annual General Meeting, including voting outcomes on six proposals: election of twelve directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory vote on named executive officer compensation, renewal of board authority to issue shares, renewal of pre-emption rights opt-out authority, and authorization for share repurchases. The filing presents detailed voting tallies (FOR, AGAINST, ABSTAIN, BROKER NON-VOTE) for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:25:42.724460+00:00","company_name":"Medtronic plc","ticker":"MDT","filing_date":"2026-10-19"},{"id":40393,"accession_number":"0001628280-26-066291","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Medtronic announced the completion of its separation of MiniMed Group, Inc., including settlement of an exchange offer whereby Medtronic exchanged all remaining shares of MiniMed common stock (252,813,348 shares) for Medtronic ordinary shares. This represents the completion of a material disposition and change of control event—a spin-off or separation of a significant business unit that would materially affect the registrant's asset base and strategic focus.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:25:42.724460+00:00","company_name":"Medtronic plc","ticker":"MDT","filing_date":"2026-10-19"}]}